TYPE 2 DIABETES: The costs and benefits of SGLT2 inhibitors & GLP-1 RAs.

Press/Media: Press / Media

PeriodJul 1 2019

Media coverage

2

Media coverage

  • TitleTYPE 2 DIABETES: The costs and benefits of SGLT2 inhibitors & GLP-1 RAs.
    Media name/outletInternal Medicine News
    CountryUnited States
    Date7/1/19
    PersonsMarc Goldschmidt
  • TitleTYPE 2 DIABETES: The costs and benefits of SGLT2 inhibitors & GLP-1 RAs.
    Media name/outletFamily Practice News
    CountryUnited States
    Date7/1/19
    PersonsMarc Goldschmidt